Literature DB >> 20396548

Prospect of anticancer therapy.

Hee-Sook Park1.   

Abstract

Year:  2004        PMID： 20396548      PMCID： PMC2855098          DOI： 10.4143/crt.2004.36.2.100

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN： 1598-2998            Impact factor:   4.679


× No keyword cloud information.
  15 in total

Review 1.  Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia.

Authors:  B J Druker; N B Lydon
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

2.  Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS.

Authors:  E Cohen-Jonathan; R J Muschel; W Gillies McKenna; S M Evans; G Cerniglia; R Mick; D Kusewitt; S M Sebti; A D Hamilton; A Oliff; N Kohl; J B Gibbs; E J Bernhard
Journal:  Radiat Res       Date:  2000-08       Impact factor: 2.841

3.  Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.

Authors:  G Schiedner; N Morral; R J Parks; Y Wu; S C Koopmans; C Langston; F L Graham; A L Beaudet; S Kochanek
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

Review 4.  The use of chemotherapy resistance in cancer treatment.

Authors:  A B Deisseroth; G Pizzorno
Journal:  Cancer J Sci Am       Date:  1997 Mar-Apr

Review 5.  Gene therapy strategies for tumor antiangiogenesis.

Authors:  H L Kong; R G Crystal
Journal:  J Natl Cancer Inst       Date:  1998-02-18       Impact factor: 13.506

Review 6.  Clinical implications of the p53 tumor-suppressor gene.

Authors:  C C Harris; M Hollstein
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

7.  Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions.

Authors:  T Takahashi; D Carbone; T Takahashi; M M Nau; T Hida; I Linnoila; R Ueda; J D Minna
Journal:  Cancer Res       Date:  1992-04-15       Impact factor: 12.701

Review 8.  Practical management of patients with chronic myeloid leukemia receiving imatinib.

Authors:  Michael W N Deininger; Stephen G O'Brien; John M Ford; Brian J Druker
Journal:  J Clin Oncol       Date:  2003-03-13       Impact factor: 44.544

9.  Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.

Authors:  D H Gorski; M A Beckett; N T Jaskowiak; D P Calvin; H J Mauceri; R M Salloum; S Seetharam; A Koons; D M Hari; D W Kufe; R R Weichselbaum
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

Review 10.  Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy.

Authors:  J Mendelsohn
Journal:  Clin Cancer Res       Date:  1997-12       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.